Management
Steve Parkinson, President and CEO, has 25 years experience in the biopharmaceutical industry, including four CEO roles over the last ten years, one of them as founder and CEO of TranXenoGen, a company he took public on London AIM and achieved a $250M valuation within a year.
Pete Ceccacci, Chief Financial Officer, has over 30 years experience in public accounting and finance including shareholder in one of the top 40 public accounting firms in the US, a member of the Baker Tilly (International Accounting Group). Mr. Ceccacci is a Certified Public Accountant since 1981 specializing in the healthcare industry as an auditor, accountant, and consultant.
Paul DiTullio, Vice President, Product Development has 19 years experience in the biotechnology/biopharmaceutical industry. Previously Co-Founder and VP Product Development of TranXenoGen Inc. and Research Scientist, Genzyme Transgenics Corp., Mr. DiTullio's experience includes a broad range of scientific, finance, and business disciplines associated with early stage product, technology and biotechnology company development.
|
|